$HYPR

HALE BRETT sold $10K of HYPR

HALE BRETT (CFO and CAO) sold 6,047 shares of Hyperfine, Inc. (HYPR) at $1.65 on 2026-05-26.

Original reporting
SEC EDGAR · HALE BRETT
Published May 27, 2026, 8:26 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 27, 2026, 8:36 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$HYPR
Neutral
medium confidence
Mentioned
$HYPR
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$HYPRNeutralLow
01

Why it matters

This is a disclosure of an open-market sale; without earnings, guidance, trial, or deal updates, it provides limited incremental information for trading.

02

Market read

Traders may monitor for clustering of insider sales, but this single small sale alone is unlikely to drive sustained repricing.

03

What to watch

No 10b5-1 plan is cited; however, absence of a plan does not confirm intent, and the filing lacks context on tax/financial planning.

Relevance 6/10Timing: Immediate (filed 2026-05-27) but effect likely short-lived given small size and lack of fundamental catalyst.

Background

SEC Form 4 insider transaction: officer/direct sale by Hyperfine CFO and CAO Hale Brett.

Company-level read

Ticker impact

$HYPRNeutralMedium confidence
Context

Hyperfine CFO/CAO Hale Brett filed an open-market sale of 6,047 HYPR shares at $1.65 on 2026-05-26 via SEC Form 4.

Expected impact

Near-term impact likely limited; any reaction may fade unless paired with other company-specific catalysts.

Evidence & confidence

Form 4 shows an officer/direct sale with no 10b5-1 plan stated, but the dollar amount (~$10k) is modest versus typical market-moving thresholds and no operational news is included.

Market effects

Minimal; this is company-specific insider activity without broader sector/regulatory implications.

None indicated.

None indicated.

Counterpoint

The sale may be for diversification or personal liquidity needs and does not necessarily reflect bearish expectations.

Key entities

  • Hyperfine, Inc.

    Subject of the Form 4 insider transaction; CFO/CAO Hale Brett sold shares.

  • HALE BRETT

    CFO and CAO who executed the open-market sale of HYPR shares.

Related articles

$HYPRHigh

Hyperfine, Inc. (HYPR): Results of Operations and Financial Condition

Hyperfine, Inc. (HYPR) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 hypr-ex99_1.htm EX-99.1 EX-99.1 Exhibit 99.1 Hyperfine, Inc. Reports Second Quarter 2026 Financial Results GUILFORD, Connecticut, August 6, 2026 (GLOBE NEWSWIRE) – Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imag